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1. Introduction
   Tragia cannabina Linn. (T. cannabina) commonly known 
as “cherukanjuru” in Tamil, India, belongs to the family 
Euphorbiaceae. It is a climbing shrub, found throughout the 
hotter parts of India. The root has been traditionally used 
in the treatment of diaphoresis and alternatively given in 
fevers to cause perspiration. A decoction of roots is useful 
in the treatment of bronchitis[1]. For diabetes mellitus it 
is one of an oriental folk medicine. This plant is used for 
the treatment of eczema, fevers, wheezing, including liver 
disorder, diabetes and viral infections[2,3]. Tragia species 
are rich in steroids, flavonoids, alkaloids and tannins. 
The literature survey revealed that the methanolic extract 
of T. cannabina posses antihyperglycemic property on 
streptozotocin (STZ) -induced diabetic rats[4]. The chemical 
examination, anticancer, antiviral and anti-inflammatory 
activity was screened for the T. cannabina extract[5-7]. 
PEER REVIEW                            ABSTRACT
KEYWORDS
AMP kinase, Chick embryo, Tragia cannabina, 4-Oxo-4H-pyran-2, 6-dicarboxylic acid bis-[6-
methyl-heptyl] ester
Objective: To investigate the in vitro antidiabetic effects of isolated 4-Oxo-4H-pyran-2,6-
dicarboxylic acid bis-[6-methyl-heptyl] ester from the chloroform extract of root of Tragia 
cannabina (T. cannabina) and AMP kinase activation property of the isolated compound. 
Methods: The roots of T. cannabina were collected and extracted with ethanol [95% v/v] then 
chromatographed over silica gel 60-120 mesh of column length 100 cm and diameter 3 cm. Elution 
was carried out with solvents and solvent mixtures of increasing polarities. Then the chloroform 
extract was used for isolation. In vitro antidiabetic activity was performed with fertile eggs of 
White Leghorn chicks by induction of diabetes by streptozotocin. 
Results: The isolated pyran ester binds very efficiently within the active pocket of AMPK with the 
formation of hydrogen bond and consuming less binding energy, which is good when compared 
to orientation of standard drug metformin. In in vitro antidiabetic evaluation by streptozotocin 
treated chick embryo the administration of isolated compound  at a doses of 0.5 mg/egg and 1 mg/
egg produced a significant reduction in the blood glucose levels in a dose dependant manner 
(P<0.01). The blood glucose level of diabetic control was (244.20依12.64) mg/dL, whereas it was (207.40
依2.43) mg/dL (P<0.001) for isolated compound 0.5 mg/egg and 174.800依2.410 mg/dL (P<0.001) for 1 
mg/ egg of the isolated compound. 
Conclusions: The significant glucose levels were reduced (P<0.01) after administration of the 
pyran ester isolated from T. cannabina to streptozotocin treated chick embryo.
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Diabetes mellitus is a group of 
metabolic diseases in which a person 
has high blood sugar, either because 
the pancreas does not produce enough 
insulin, or because cells do not respond 
to the insulin that is produced. The plant 
has got good ethanobotanical history, 
and study attempts to validate it. This 
scientific study support and suggest the 
use of this plant in treating diabetes.
Details on Page S458
Article history:
Received 10 Jan 2014
Received in revised form 18 Jan, 2nd revised form 22 Jan, 3rd revised form 1 Feb 2014
Accepted 20 Feb 2014
Available online 5 April 2014
Vaiyapuri Sivajothi and Shruthi Shirur Dakappa /Asian Pac J Trop Biomed 2014; 4(Suppl 1): S454-S459S456
Acute and subacute toxicity of alcoholic extract of the roots 
of T. cannabina was reported[8].
   Diabetes mellitus is a metabolic disorder. Chronic elevation 
of blood glucose level leads to retinopathy, neuropathy 
and peripheral vascular insufficiencies[9]. In olden days it 
was considered a disease of minor significance. In the 21st 
century, it is one of the main threads to human health. It is 
estimated that 300 million people will be affected by diabetes 
mellitus in the year 2025[10]. Increasing diabetes and obesity 
among the people in the world intensified search for new 
therapeutic treatment for diabetes mellitus[11].
   The AMP-activated protein kinase (AMPK) is a highly 
preserved sensor of cellular energy status, found in essentially 
all eukaryotic genomes[12]. It is an enzyme composed of a 
catalytic subunit (α) and two regulatory subunits (β and γ)
[13]. There are two isoforms of the catalytic subunit: AMPK α1, 
which is widely distributed, and AMPK α2, which is expressed 
in skeletal muscle, heart, and liver[14]. AMPK works as an 
intracellular fuel gauge that becomes activated by decreases 
in the ATP/ADP and phosphocreatine (PCr)/creatine ratios 
through mechanisms involving phosphorylation by one or 
more upstream AMPK kinases, allosteric activation, and a 
decrease in the inhibitory action of phosphatases[15]. The 
increase in AMPK activity stimulates the of glucose uptake 
in muscle, fatty acid oxidation in muscle and liver, and the 
inhibition of hepatic glucose production, cholesterol and 
triglyceride synthesis, and lipogenesis[16]. The AMPK system 
is a regulator of energy balance at both the cellular and 
whole-body levels, once gets activated by low energy status 
effects a switch from ATP-consuming anabolic pathways to 
ATP-producing catabolic pathways. That is why it is now 
appearing to be the major target to treat type 2 diabetes[17]. 
   The objective of the present study was to investigate the in 
vitro and in silico antidiabetic effects of isolated 4-Oxo-4H-
pyran-2,6-dicarboxylic acid bis-[6-methyl-heptyl] ester 
from the root of T. cannabina and AMP kinase activation 
property of the isolated compound.
2. Materials and methods
2.1. Plant material and preparation of plant extract
   The roots of T. cannabina were collected from the local 
area of Salem, India in the month of October 2012 and were 
authenticated by the Botanist, Botanical Survey of India, 
Coimbatore, India. A voucher specimen (ET-30) has been 
stored and maintained in our laboratory. The roots were 
shade-dried and powdered. The powder was extracted with 
ethanol (95% vol/vol) using a Soxhlet apparatus. The extract 
was dried under reduced pressure and stored in a desiccator. 
The yield of extract was 3.5% (wt/wt) thus obtained crude 
extract was used for phytochemical screening. The ethanol 
extract was chromatographed over silica gel 60-120 mesh 
of column length 100 cm and diameter 3 cm. Elution was 
carried out with solvents and solvent mixtures of increasing 
polarities. Then the chloroform extract was used for isolation.
2.2. Phytochemical screening
   The crude extract was qualitatively examined for the 
presence of various phytochemical constituents using 
standard tests described by Harborne[18].
2.3. Isolation of 4-Oxo-4H-pyran-2, 6-dicarboxylic acid 
bis-[6-methyl-heptyl] ester
   The chloroform extract (5.5 g) was chromatographed over 
silica gel 60-120 mesh of column length 100 cm and diameter 
3 cm. Elution was carried out with solvents and solvent 
mixtures of increasing polarities. The fractions were collected 
in 15 ml portions and monitored on TLC. The fractions that 
showed similar spots were combined. The fractions 133-146 
eluted in ethyl acetate: chloroform (10:90) solvent system, 
yielded a yellow coloured residue and the TLC profile 
showed three spots, with one major and two minor spots and 
rechromatographed for further purification. The yellow residue 
(0.150 g) obtained in this fraction was further chromatographed 
over silica gel 100-200 mesh of column length 75 cm and 
diameter 1.2 cm. Elution was carried out with solvents and 
solvent mixtures of increasing polarities. The fractions 
were collected in 15 ml portions and monitored on TLC. The 
fractions 106-135 eluted in ethyl acetate: chloroform (10:90) 
solvent system, showed one major and one minor spots on TLC. 
It was further purified by PTLC in ethyl acetate: chloroform 
(20:80) solvent system, a band showing Rf value 0.544 and 
recrystallised in absolute alcohol to yield a yellow semi solid 
designated as isolated compound and the yield was 4.5 mg. 
This compound was subjected to physical and spectral studies 
for confirming the purity and characterization. The remaining 
fractions were not worked out because of lesser yields.
2.4. Effect of on STZ treated chick embryo
   STZ was first reported to have a specific diabetogenic 
effect[19]. In an attempt to reduce the number of mammals 
used in drug research, the use of chick embryos found 
superior for predicting the effects of drugs[20-22]. Pancreas 
of chick embryo lies in duodenum that consists of a long 
U-shaped loop. It begins to develop rapidly during the 5th day 
of incubation and to acquire its definitive structure by 12th 
day of incubation[23]. β cells secrete insulin from the 4th or 5th 
day of incubation. The level of serum insulin in chick embryos 
increases gradually after the 12th day of incubation. The 
mechanism of induction of diabetes by STZ was not known.
2.5. Selection of animals
   Fertile eggs of White Leghorn chicks were obtained from 
poultry, incubated at (37.5依0.2) °C at a relative humidity of 
about 65%, turned automatically every hour.
2.6. Experimental induction of diabetes
   Fertile eggs of White Leghorn chicks obtained from poultry 
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were incubated at (37.5依0.2) °C at a relative humidity of 
about 65%, turned automatically every hour. For induction 
of diabetes, STZ was dissolved in physiological saline and 
sterilized through a membrane filter. A total of 300 µg/egg of 
STZ was injected into the albumen of fertile eggs on the 14th 
day of incubation.
2.7. Sample collection
   Large vitelline veins of eggs were selected and marked 
by pencil under the florescent lamb. Eggshell of a marked 
range of 10伊5 mm was removed by electrical drill and a drop 
of water was filled to project clearly an artery. Whole blood 
was collected from a vein of egg by means of a tuberculin 
syringe with a 0.55伊32 mm needle. The collected blood 
samples were immediately centrifuged at 2000 r/min for 15 
min. The serum separated out was collected in fresh serum 
tubes and stored in refrigerator (2-4) °C after tightly capped 
until analysis.
2.8. Experimental design
   After the induction of diabetes the eggs were divided into 
seven groups of ten each as detailed bellow. Group I, Control 
eggs received the vehicle (saline injected into the albumen 
on 17th day); Group II, Diabetic control received the vehicle 
(saline injected into the albumen on 17th day); Group III, 
Diabetic control received isolated compound (0.5 mg/egg 
injected into the albumen on 17th day); Group IV, Diabetic 
control received isolated Compound (1 mg/egg injected into 
the albumen on 17th day); Group V, Diabetic control received 
insulin (4 U/egg injected into the albumen on 17th day).
   The blood sample was collected on the 17th day of 
incubation before and after 5 min of injection of the 
compound and insulin. Then blood glucose was analyzed 
using strip method.
2.9. In silico docking studies
   AutoDock tools was utilized to generate grids, calculate 
dock score and evaluate the conformers of inhibitors bound 
in the active site of AMPK as targets for antidiabetic activity. 
Automated docking is a graphical user interface. AutoDock 
3.0 was employed to get docking and binding scores; which is 
implemented by Lamarckian genetic algorithm method. The 
ligand molecules Pyran ester and Metformin were designed 
and the structure was analyzed using ChemDraw Ultra 6.0. 
The PRODRG server was used to minimise energy of drug 
compounds and 3D coordinates were prepared. The protein 
structure file (PDB ID: 1ZON) was taken from PDB and was 
edited by removing the hetero atoms and C terminal oxygen 
was added using SwissPDB viewer. The grid map was centred 
at particular residues of the protein and was generated with 
AutoGrid. As per genetic algorithm all the torsions were 
allowed to rotate during docking. The Lamarckian genetic 
algorithm and the pseudo-Solis and Wets methods were 
applied for minimization, using default parameters[24-27].
2.10. Statistical analysis
   All data were expressed as the means依standard deviation 
(SD). Student’s t-test was used to arrive at the statistically 
significant changes associated with various treatments. 
P<0.05 was regarded as significant.
3. Results 
   The chloroform extract was extracted from the root of T. 
cannabina and the preliminary phytochemical screening 
of crude extract indicates the presence of flavonoids, 
glycosides, triterpenoids, saponins and tannins. The crude 
extract was subjected to column chromatography to get 
4-Oxo-4H-pyran-2, 6-dicarboxylic acid bis-(6-methyl-
heptyl) ester (Figure 1). The IR (KBr) spectrum showed 
absorptions for three carbonyl groups (1 739, 1 700 and 1 696 
cm-1), unsaturation (1 650 cm-1), isopropyl unit (1 380 and 
1 461 cm-1) and ether group (1 171 cm-1). 1H-NMR (DMSO) 
spectrum exhibits two sets of doublet signals at δ 0.85 and 
0.91 integrating for six protons each for isopropyl methyl 
groups. A 18 proton broad multiplet signals from δ 1.28 to 
2.38 region were due to eight methylene and two methane 
protons present in identical environment showing the 
presence of long aliphatic side chain. It displayed signals 
at δ 5.40 integrated for two protons indicating the presence 
of two unsaturated protons it also displayed two multiplet 
signals at δ 4.00 and 4.63 each for two protons for two oxy 
methylene groups. 13C NMR exhibited three carbonyl groups 
at δ 227.70 a keto group and at δ 178.54 and 177.37 for two 
ester carbonyl groups. The signals at δ 148.50, 148.19, 107.79 
and 107.51 were assigned to two carbon-carbon double 
bonds. The carbon of the oxy methylene group resonated 
at δ 58.12 and the remaining carbon chain of the long 
chain hydrocarbon moiety resonated from δ 49.09 to δ 
12.25. Absence of any signal beyond δ 5.5 in H1-NMR and 
appearance of only four peaks in the unsaturated region of 
13
C-NMR spectrum indicates the absence of benzene ring 
system in compound. In MASS spectrum, the molecular 
ion peak was observed at m/z 408 which indicated that the 
molecular weight of the compound. The melting point of the 
compound was recorded on electro thermal melting point 






Figure 1. 4-Oxo-4H-pyran-2,6-dicarboxylic acid bis-[6-methyl-heptyl] 
ester.
   The blood glucose level of diabetic control was (244.20依
12.64) mg/dL, whereas it was (214.400依2.243) mg/dL (P<0.001) 
for compound 0.5 mg/egg and (186.200依2.631) mg/dL (P<0.001) 
for 1 mg/egg of the compound. The significant glucose levels 
Vaiyapuri Sivajothi and Shruthi Shirur Dakappa /Asian Pac J Trop Biomed 2014; 4(Suppl 1): S454-S459S458
were reduced (P<0.01) after administration of the compound 
(Table 1). The pyran ester binds very efficiently within the 
active pocket of AMPK with the formation of 1 hydrogen bond 
with its amino acid Gln 109 of C chain. The result obtained 
is comparable to orientation of standard drug (Figure 2). The 
binding energy required is almost similar to that of standard 
Metformin as shown in Table 2. Studies related to improving 
its structure where it requires less binding energy to dock 
are in progress. Hence, the above pyran ester can be 
considered as effective treatment against diabetes. 
Table 1
Effect of isolated compound on STZ treated chick embryo.
Design of Treatment Dose (mg/kg) Blood glucose (mg/dL)
Control - 156.55依2.286
Saline control - 151.00依2.150
Diabetic control -  244.20依2.640b
Compound  0.5 mg/egg  214.40依2.243a
Compound 1.0 mg/egg 186.20依2.631a
Insulin 4 U/egg 157.60依1.986a
Values represent mean依SEM (n=6), aP<0.001 v.s diabetic control, bP<0.01 v.s 





Figure 2. (a) Structure of ampk as seen in proteinscope viewer; (b) orientation 
of pyran ester in the active pocket of ampk; (c) enfolding of metformin in 
active pocket. 
4. Discussion 
   The world’s largest growing metabolic disorder is diabetes 
mellitus. Alternative strategies are required to manage diabetes 
other than modern medicine due to its enormous costs. The 
present manuscript discusses about the antidiabetic effects of 
pyran ester isolated from the chloroform extract of the root of 
T. cannabina on STZ induced egg embryo.  
   The chloroform extract was extracted from the root of T. 
cannabina. The preliminary phytochemical screening was 
done for the extract and subjected to isolation for compounds. 
In the present study, column chromatography and TLC eluted 
a compound. Based on IR, H1-NMR, 13C- NMR and MASS 
spectrum the compound was interpreted as 4-Oxo-4H-
pyran-2,6-dicarboxylic acid bis-(6-methyl-heptyl) ester. 
Administration of isolated compound at a doses of 0.5 mg/egg 
and 1 mg/egg produced a significant reduction in the blood 
glucose levels in a dose dependent manner (P<0.01). The pyran 
ester had showed good binding efficiency in docking studies. 
The results obtained in in silico studies are in correlation with 
the in vitro studies. It has demonstrated a dose dependant 
efficacy. More study is required on its effects in vivo and to 
also evaluate its bio-safety and clinical potentials. However, 
experimental validation of the predicted compound in this 
direction is needed.
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Comments 
Background
   Diabetes mellitus is characterized by insulin resistance, 
which may be combined with relatively reduced insulin 
secretion. The defective responsiveness of body tissues to 
insulin is believed to involve the insulin receptor. However, 
the specific defects are not known. Diabetes mellitus cases 
due to a known defect are classified separately. Type 2 
diabetes is the most common type. Diabetes also damages the 
capillaries. Diabetic retinopathy, which affects blood vessel 
formation in the retina of the eye, can lead to visual symptoms 
including reduced vision and potentially blindness.
Research frontiers
   The present investigate the in vitro and in silico 
antidiabetic effects of isolated 4-Oxo-4H-pyran-2,6-
dicarboxylic acid bis-(6-methyl-heptyl) ester from the root 
Table 2
Molecular docking results of AMPK.
Compounds Binding energy Docking energy Inhibitory constant H-bonds Bond formation
PE -3.50 -6.68 0.0 1 1A::DRG1:OAH::AMPK:C:GLN109:HN
MF -5.54 -5.54 8.69e-005 1 MF::DRG1:HAB::AMPK:A:THR106:OG1
PE- Pyran ester, MF-Metformin
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extract of T. cannabina and AMP kinase activation property 
of the isolated compound.
Related reports
   The study validates ethanobotanical claim of plant. 
Standard experimental methods have been employed for both 
in vitro and in silico studies.
Innovations and breakthroughs
   Plant is used as an oriental folk medicine in diabetes 
mellitus. The increase in AMPK activity stimulates the of 
glucose uptake in muscle, fatty acid oxidation in muscle 
and liver, and the inhibition of hepatic glucose production, 
cholesterol and triglyceride synthesis, and lipogenesis. The 
study orients towards deducing the relation between above 
mentioned facts in vitro and in silico.
  
Applications
   The scientific analysis done support and suggest the use of 
this plant in treating diabetes. It also proves target specific 
drug treatment through docking studies.
Peer review
   Diabetes mellitus is a group of metabolic diseases in which 
a person has high blood sugar, either because the pancreas 
does not produce enough insulin, or because cells do not 
respond to the insulin that is produced. The plant has got 
good ethanobotanical history, and study attempts to validate 
it. This scientific study support and suggest the use of this 
plant in treating diabetes.
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